Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Non-Current Deferred Tax Liability (2016)

Aptevo Therapeutics (APVO) has disclosed Non-Current Deferred Tax Liability for 2 consecutive years, with $15.8 million as the latest value for Q2 2016.

  • Quarterly Non-Current Deferred Tax Liability changed N/A to $15.8 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $15.8 million through Jun 2016, changed N/A year-over-year, with the annual reading at $15.8 million for FY2015, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability hit $15.8 million in Q2 2016 for Aptevo Therapeutics, roughly flat from $15.8 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $15.8 million in Q4 2015 to a low of $15.8 million in Q4 2015.